HSPB1 Gene CMT2F Genetic Test
Test Name: HSPB1 Gene CMT2F Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for HSPB1 Gene CMT2F NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with HSPB1 Gene CMT2F.
Test Details: The HSPB1 gene is associated with Charcot-Marie-Tooth disease type 2F (CMT2F), which is a rare genetic disorder that affects the peripheral nerves and causes muscle weakness and atrophy. The NGS genetic test for CMT2F analyzes the HSPB1 gene for mutations that can cause the disease. This test is useful for individuals who have symptoms of CMT2F or have a family history of the disease. Early diagnosis can help with the management of symptoms and treatment options. The test is performed using next-generation sequencing (NGS) technology, which can analyze multiple genes simultaneously and provide accurate results. Genetic counseling is recommended before and after the test to discuss the implications of the results and the risk of passing the mutation to future generations.
Test Name | HSPB1 Gene CMT2F Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for HSPB1 Gene CMT2F NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with HSPB1 Gene CMT2F |
Test Details | The HSPB1 gene is associated with Charcot-Marie-Tooth disease type 2F (CMT2F), which is a rare genetic disorder that affects the peripheral nerves and causes muscle weakness and atrophy. The NGS genetic test for CMT2F analyzes the HSPB1 gene for mutations that can cause the disease. This test is useful for individuals who have symptoms of CMT2F or have a family history of the disease. Early diagnosis can help with the management of symptoms and treatment options. The test is performed using next-generation sequencing (NGS) technology, which can analyze multiple genes simultaneously and provide accurate results. Genetic counseling is recommended before and after the test to discuss the implications of the results and the risk of passing the mutation to future generations. |